➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Moodys
AstraZeneca
Harvard Business School
Boehringer Ingelheim
Baxter

Last Updated: September 20, 2020

DrugPatentWatch Database Preview

TRIMIPRAMINE MALEATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Trimipramine Maleate, and when can generic versions of Trimipramine Maleate launch?

Trimipramine Maleate is a drug marketed by Crossmedika Sa, Elite Labs Inc, and Usl Pharma. and is included in five NDAs.

The generic ingredient in TRIMIPRAMINE MALEATE is trimipramine maleate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trimipramine maleate profile page.

US ANDA Litigation and Generic Entry Outlook for Trimipramine Maleate

A generic version of TRIMIPRAMINE MALEATE was approved as trimipramine maleate by ELITE LABS INC on August 2nd, 2006.

  Start Trial

Drug patent expirations by year for TRIMIPRAMINE MALEATE
Drug Prices for TRIMIPRAMINE MALEATE

See drug prices for TRIMIPRAMINE MALEATE

Pharmacology for TRIMIPRAMINE MALEATE
Medical Subject Heading (MeSH) Categories for TRIMIPRAMINE MALEATE

US Patents and Regulatory Information for TRIMIPRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Crossmedika Sa TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-001 Apr 15, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071283-001 Dec 8, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Elite Labs Inc TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 077361-001 Aug 2, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Usl Pharma TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 071284-001 Dec 8, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Crossmedika Sa TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-002 Apr 15, 2016 AB RX No Yes   Start Trial   Start Trial   Start Trial
Crossmedika Sa TRIMIPRAMINE MALEATE trimipramine maleate CAPSULE;ORAL 208127-003 Apr 15, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
AstraZeneca
Express Scripts
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.